Sansure Biotech has played a significant role in the global fight against COVID-19, developing and supplying nucleic acid testing kits for the virus. In this blog, we’ll explore how Sansure has contributed to the fight against COVID-19, and the impact of their products on the pandemic response.
Rapid Development of COVID-19 Testing Kits
Sansure Biotech was one of the first companies in China to develop a nucleic acid testing kit for COVID-19. The company quickly scaled up production and began supplying the kits to hospitals and clinics. The kits use a polymerase chain reaction (PCR) amplification method, which allows for highly sensitive and specific detection of the virus.
Rapid Global Expansion of Sales
Sansure Biotech’s COVID-19 testing kits were approved for use in multiple countries. The company quickly expanded its sales network, and began exporting its products to many countries worldwide. This enabled countries to rapidly scale up their testing capabilities.
Significant Contribution to Pandemic Response
Sansure Biotech’s testing kits have been widely used in the global response to the COVID-19 pandemic. The kits have enabled rapid and accurate detection of the virus, allowing for effective control measures to be implemented. Sansure Biotech’s contribution to the pandemic response has been widely recognized, with the company receiving awards and accolades all over the world.
In conclusion, Sansure Biotech’s testing kits products have made a significant contribution to the global response to the pandemic. The company’s rapid development and production of the kits, as well as its global expansion of sales, has enabled countries to rapidly scale up their testing capabilities, helping to control the spread of the virus.